RxDoctor Payments Data

Mary Johansen, APRN

Adult Health · Deerfield, ILNPI 1689208928

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Boehringer Ingelheim at 24.3% of the total. Reporting peaked in 2021 at $1,345 and has fallen 94.4% since, to $75 in 2023.

$2,403in general payments, 2019–2025

Across 109 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$584
  • AstraZeneca$562
  • GSK$386
  • Sanofi$176
  • Regeneron Healthcare Solutions, Inc.$146
  • Amgen$135
  • plus $414 from 9 others

What the payments were for

  • Food & beverage$2,403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,403 in reported general payments places this provider in the 85th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois →

Medicare billing

Part B allowed, 2024
$9,635
Medicare patients
49
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium36$207
Metoprolol Succinate19$101
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$78
Cefadroxil11$64
Prednisone18$54
Amlodipine Besylate23$41
Furosemide13$34

Paid to pharmacies, not to this prescriber.

Other adult health in Deerfield

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →